Previous close | 231.77 |
Open | 231.91 |
Bid | 0.00 x 900 |
Ask | 0.00 x 900 |
Day's range | 229.58 - 237.56 |
52-week range | 167.42 - 261.73 |
Volume | |
Avg. volume | 948,695 |
Market cap | 42.398B |
Beta (5Y monthly) | 1.52 |
PE ratio (TTM) | 31.95 |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
IQVIA Holdings' (IQV) first-quarter 2024 revenues are likely to have benefited from growth in the Technology and Analytics, and Research and Development segments.
Looking beyond Wall Street's top -and-bottom-line estimate forecasts for IQVIA (IQV), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended March 2024.
In this article, we will be taking a look at the 20 fastest growing health tech companies in the world. If you do not want to learn about the trends in digital health market, head straight to the 5 Fastest Growing Health tech Companies in the World. Explosive Growth and Key Trends in the Digital […]